Data protection Impressum

Biotech

The Swiss Institute of Bioinformatics has inaugurated its Centre for Pathogen Bioinformatics in Lausanne to enhance pathogen research and surveillance.

SIB launches the Centre for Pathogen Bioinformatics to strengthen global pandemic response

28 October 2024

Lonza expands its collaboration with a major biopharma partner, adding a new bioconjugation suite in Visp to support advanced cancer therapy manufacturing.

Lonza expands its manufacturing capabilities in Visp and creates 100 new jobs

23 October 2024

Nestled in the quiet industrial zone of Domdidier, in the canton of Fribourg, Medistri has grown into a key player in the highly specialized field of sterilization for medical and pharmaceutical industries.

Medistri, Fribourg’s hidden champion in medtech and pharmaceutical sterilization

22 October 2024

Switzerland has long been known as a global hub for cutting-edge innovation, and the recent visit of the Club de Paris des Directeurs de l'Innovation provided a unique opportunity to showcase the vibrant ecosystem in Western Switzerland. Co-organized by Greater Geneva Bern area (GGBa), this three-day learning journey brought together leaders and innovators from various sectors, eager to explore and exchange ideas on technological advancement and collaboration.

Discovering Swiss Innovation with the Club de Paris des Directeurs de l’Innovation

21 October 2024

Atinary Technologies and Snapdragon Chemistry, a Cambrex company, have announced a strategic collaboration to integrate AI-driven process optimization technology with advanced pharmaceutical development capabilities, aiming to revolutionize drug development.

Atinary Technologies and Snapdragon Chemistry partner to optimize drug development with AI

9 October 2024

The newly inaugurated Genolier Innovation Hub, a 270,000-square-foot facility, offers companies, researchers and healthcare professionals an interdisciplinary platform to foster medical breakthroughs, backed by a CHF 100 million investment.

The Genolier Innovation Hub, a cutting-edge medical innovation center, was inaugurated

30 September 2024

A Memorandum of Understanding (MOU) between KoreaBIO and the Switzerland Innovation Park West EPFL was signed during the Korea-Switzerland Partnering Day, strengthening industrial cooperation and joint research in biotech.

Switzerland strengthens biotech collaboration with KoreaBIO through new MOU

30 September 2024

HAYA Therapeutics has announced a multi-year collaboration with Eli Lilly, potentially earning up to USD 1 billion in milestone payments to advance RNA-guided therapies for obesity and metabolic disorders.

HAYA Therapteutics enters major collaboration to advance RNA-based drug discovery

17 September 2024

Biotech Vandria has raised an additional CHF 14 million to accelerate the development of innovative treatments for age-related and chronic diseases, bringing its total Series A financing to CHF 28.3 million.

Vandria secures over CHF 14 million to advance age-related disease therapies

3 September 2024

Relief Therapeutics has entered into an agreement with SWK Funding LLC to secure up to USD 11 million in non-dilutive financing through the sale of royalty interests to support its clinical development pipeline.

Geneva biotech Relief Therapeutics raises up to USD 11 million from royalty sales

14 August 2024

1 2 3 4 5 6 7 8 … 19